Emerging
Jun 18, 2026 Major1
77%
Artemis Framework Uses Region-Level Causal Intervention to Remove Confounders in Multimodal Brain Imaging
Artemis, a new AI framework for multimodal neuroimaging, uses region-level causal interventions to eliminate confounding demographic factors like age and sex that affect brain connectivity analysis. The method integrates fMRI and DTI data and works as a plug-in module with various graph neural network architectures, demonstrating consistent improvements on disease diagnosis, dementia staging, and sex classification benchmarks.
Quick Facts
Who
Researchers (institutional affiliation not specified in sources)
What
Developed Artemis framework for multimodal neuroimaging
When
Submitted 10 June 2026
Where
arXiv (Computer Science > Machine Learning)
- Developed Artemis framework for multimodal neuroimaging
- Implements region-level causal interventions
- Learns region-specific confounder representations
- Integrates functional and structural connectivity data
- Tested on ADNI, OASIS, and HCP datasets
Researchers have introduced Artemis, a novel artificial intelligence framework designed to address a critical challenge in multimodal neuroimaging: the confounding effects of demographic factors such as age and sex on the relationship between brain connectivity and clinical outcomes. The framework integrates functional connectivity data from fMRI and structural connectivity data from DTI, enabling comprehensive analysis of brain networks while accounting for region-specific variations in demographic sensitivity.
The core innovation of Artemis lies in its region-level causal intervention approach. Rather than applying uniform adjustments across the entire brain, the framework learns region-specific confounder representations by performing causal interventions at each brain region independently. This anatomy-resolved strategy reflects the biological reality that different brain regions exhibit distinct sensitivities to demographic confounders. The method operates as a plug-in module compatible with various graph neural network (GNN) backbones, making it adaptable to existing computational architectures.
Graphs neural networks have become standard tools for analyzing brain connectivity data, but they can exploit spurious correlations when confounding factors are not properly managed. Previous causal GNN methods introduced causality at the graph-modeling level but remained domain-agnostic, failing to account for the real-world confounders inherent in clinical neuroimaging. Artemis bridges this gap by incorporating domain-specific knowledge from neuroimaging and clinical practice.
The framework was evaluated on three diverse benchmarks representing different clinical applications. The ADNI dataset was used for disease diagnosis, OASIS for dementia staging, and HCP (Human Connectome Project) for sex classification tasks. Results demonstrated consistent improvements over representative GNN-based baselines across all three benchmarks. Supporting experiments verified both statistical significance and neuroscientific interpretability of the findings, suggesting the method successfully learns causally invariant representations rather than relying on spurious shortcuts.
The research addresses a fundamental problem in translating neuroimaging analyses to clinical practice: demographic confounders can obscure the true relationship between brain connectivity patterns and health outcomes. By eliminating these confounders at the anatomical region level, Artemis aims to improve the reliability and clinical applicability of brain network analyses derived from multimodal imaging data.
Why This Matters
This research directly improves the clinical reliability of brain imaging analysis by addressing a persistent problem: demographic confounders like age and sex can mask the true relationship between brain connectivity and disease. By removing these confounders at the anatomical region level, Artemis enhances diagnostic accuracy and makes neuroimaging findings more translatable to real-world clinical practice. Organizations using brain imaging for disease detection, patient monitoring, or research can adopt this framework to reduce false positives and strengthen evidence for treatment decisions.
Timeline & Sources
Jun 10, 2026
WireArtemis framework submitted to arXiv
Jun 18, 2026
WireArtemis framework published on arXiv (Computer Science > Machine Learning)